• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,584.84 71.29
(0.14%)
Dow Jones
7,519.91 78.81
(1.06%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.51 -0.04
(-0.04%)
EUR-INR
109.43 -0.23
(-0.21%)
GBP-INR
126.51 -0.33
(-0.26%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.3150344
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
27.56
36306.8
EPS(TTM)
Face Value()
Div & Yield %
79.87
1
0.91
 

Pakka CFO Neetika Suryawanshi resigns
Jun 16,2026
According to the company's regulatory filing, her resignation will take effect from the close of business hours on 30 June 2026.

Pakka is mainly engaged in the business of manufacturing and dealing in Paper and Moulded products The company’s standalone net profit fell 69.5% to Rs 3.84 crore in Q4 FY26 as against Rs 12.57 crore posted in Q4 FY25. However, revenue from operations rose 10.2% to Rs 101.54 crore posted in the quarter ended 31 March 2026.

Shares of Pakka rose 2.25% to close at Rs 82.80 on the BSE.